RxDoctor Payments Data

Jack Jallo, MD

Neurological Surgery · Philadelphia, PANPI 1720076706

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Spineology Inc. at 46.6% of the total. 2025 is the largest year on record at $4,755, more than ten times the $89 reported in 2019.

$6,874in general payments, 2019–2025

Across 42 payments — averaging $163.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Spineology Inc.$3K
  • Stryker$2K
  • Arthrex$921
  • Paladin Technology Solutions$506
  • CTL Medical Corporation$142
  • VB Spine LLC$70
  • plus $146 from 3 others
$115,163in research payments, 2019–2025

Across 12 payments — averaging $9596.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Biogen$83K
  • Stryker$22K
  • Tyber Medical, LLC$6K
  • Paradigm Spine, LLC$4K

What the payments were for

  • Speaking & faculty fees$3,20047%
  • Travel & lodging$1,38320%
  • Food & beverage$2,29133%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Spineology Inc.1$3,200
Stryker28$1,889
Arthrex4$921
Paladin Technology Solutions1$506
CTL Medical Corporation2$142
VB Spine LLC2$70
Natus Medical Incorporated2$67
Johnson & Johnson1$44
Zimmer Biomet1$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,874 in reported general payments places this provider in the 65th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$475,346
Medicare patients
378
Services billed
1,196

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →